19
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      Call for Papers: Novel Methods in Vascular and Lymphatic Physiology

      Submit here before June 30, 2025

      About Journal of Vascular Research: 1.8 Impact Factor I 3.4 CiteScore I 0.486 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Patterns of Aortic Valve Replacement in Europe: Adoption by Age

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: The management of patients with severe aortic stenosis may differ according to patients’ age. The aim of this analysis was to describe patterns of aortic valve replacement (AVR) use in European countries stratified by age. Methods: Procedure volume data for AVR, including surgical aortic valve replacement (sAVR) and transcatheter aortic valve implantation (TAVI), for the years 2015–2020 were obtained from national databases for twelve European countries (Austria, the Czech Republic, Denmark, England, Finland, France, Germany, Norway, Poland, Spain, Sweden, and Switzerland). Procedure volumes were reported by patient age (<50 years, 5-year age groups between 50 and 85 years, and ≥85 years). Patients per million (PPM) population undergoing AVR each year were calculated using population estimates from Eurostat. Results: AVR PPM varied widely between countries, from 508 PPM in Germany to 174 PPM in Poland in 2020. TAVI rates ranged from 61% in Switzerland and Finland to 25% in Poland. AVR PPM increased with age to a peak at 80–84 years, after which it decreased again. AVR procedures increased from 2015 to 2019 at an average annual rate of 3.9%. AVR increased more substantially in people aged ≥80 years than in younger age groups; these older age groups accounted for 30% of all AVR procedures in 2015 and 35% in 2019. TAVI accounted for an increasing proportion of all AVR procedures as patient age increased; an overall average of 96% of males and 98% of females aged ≥85 years received TAVI as the treatment modality, although adoption of TAVI differed between countries. Conclusions: There is considerable variation in the rates of AVR use and the adoption of TAVI versus sAVR between European countries. The use of TAVI has increased in recent years, particularly for older patients.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          2023
          December 2023
          16 August 2023
          : 148
          : 6
          : 547-555
          Affiliations
          [_a] aGeneral and Interventional Cardiology/Angiology, Heart and Diabetes Centre Nord Rhine-Westphalia, University Hospital of the Ruhr University Bochum, Bad Oeynhausen, Germany
          [_b] bCardiology, Liverpool Heart and Chest Hospital, Liverpool, UK
          [_c] cHeart Institute, Department of Cardiology, Hospital University Germans Trias I Pujol Barcelona, Badalona, Spain
          [_d] dDepartment of Cardiology, Normandie University, UNIROUEN, U1096, CHU Rouen, Rouen, France
          [_e] eDepartment of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
          [_f] fDivision of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria
          [_g] gDivision of Cardiology and Structural Heart Diseases, Medical University of Silesia in Katowice, Katowice, Poland
          [_h] hEdwards Lifesciences, Nyon, Switzerland
          [_i] iMedical Affairs, Edwards Lifesciences, Prague, Czechia
          [_j] jInstitute for Pharmacology und Preventive Medicine, Cloppenburg, Germany
          [_k] kDepartment of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, University Hospital, Ruhr-University Bochum, Bad Oeynhausen, Germany
          Author notes
          *Tanja Rudolph, trudolph@hdz-nrw.de
          Article
          533633 Cardiology 2023;148:547–555
          10.1159/000533633
          37586346
          c9c4fa18-9527-44d2-8811-bcd31809d04f
          © 2023 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.

          History
          : 13 June 2023
          : 10 August 2023
          Page count
          Figures: 3, Tables: 1, Pages: 9
          Funding
          We acknowledge the financial support provided by Edwards Lifesciences to the Institute for Pharmacology and Preventive Medicine (Cloppenburg, Germany).
          Categories
          Valvular Heart Disease: Research Article

          Medicine
          Age,Aortic valve replacement,Transcatheter aortic valve implantation,Europe
          Medicine
          Age, Aortic valve replacement, Transcatheter aortic valve implantation, Europe

          Comments

          Comment on this article